I starting reading the Entain accounts and my prior assumption seems correct regarding the valuation of the NZ intangible assets. It would appear that the main intangible asset is the exclusive 25 yr NZ License. From the report:
Intangible assets
Intangible assets acquired separately are capitalised at cost and those acquired as part of a business combination are capitalised separately from goodwill. The costs relating to internally generated intangible assets, principally software costs, are capitalised if the criteria for recognition as assets are met. Other expenditure is charged in the year in which the expenditure is incurred. Following initial recognition, intangible assets are carried at cost less any accumulated amortisation and any accumulated impairment losses.
The useful lives of these intangible assets are assessed to be either finite or indefinite. Indefinite lived assets are not amortised and are subject to an annual impairment review from the year of acquisition. Where amortisation is charged on assets with finite lives, this expense is taken to the consolidated income statement through the ‘operating expenses, depreciation and amortisation’ line item.
The useful lives applied to the Group’s intangible assets are as follows:
Exclusive New Zealand licence 25–year duration of licence
Other licences Lower of 15 years, or duration of licence Software – purchased & internally capitalised costs 2–15 years
Trademarks & brand names 10–25 years, or indefinite life Customer relationships 3–15 years
The useful lives of all intangible assets are reviewed at each financial period end. Impairment testing is performed annually for intangible assets which are not subject to systematic amortisation and where an indicator of impairment exists for all other intangible assets. An intangible asset is derecognised on disposal, with any gain or loss arising (calculated as the difference between the net disposal proceeds and the carrying amount of the item) included in the consolidated income statement in the year of disposal.